The Journal of extra-corporeal technology
-
J Extra Corpor Technol · Jun 2005
Randomized Controlled Trial Clinical TrialCan lean body mass be used to reduce the dose of heparin and protamine for obese patients undergoing cardiopulmonary bypass?
Increasing numbers of obese patients are presenting for cardiac surgery. The convention for heparin dose dictates that a bolus of 300 IU heparin per kilogram of total body weight (TBW) is administered before CPB. During CPB, the activated clotting time (ACT) is maintained for longer than 480 seconds. ⋯ Additional heparin was administered as required to achieve target ACT > 400 s. Mean ACT results and total heparin doses were analyzed using unpaired two tailed t tests. Our results indicate that with care, a reduction of as much as 25% in the doses of heparin (p = 0.0001) and protamine can be achieved for a substantial number of patients classified as overweight or obese.
-
J Extra Corpor Technol · Jun 2005
ReviewGeneral anesthesia in cardiac surgery: a review of drugs and practices.
General anesthesia is defined as complete anesthesia affecting the entire body with loss of consciousness, analgesia, amnesia, and muscle relaxation. There is a wide spectrum of agents able to partially or completely induce general anesthesia. Presently, there is not a single universally accepted technique for anesthetic management during cardiac surgery. ⋯ Although many of the agents highlighted in this review are capable of producing more than one of these effects, it is logical that drugs producing these effects are given in combination to achieve the most beneficial effect. This review features a discussion of currently used anesthetic drugs and clinical practices of general anesthesia during cardiac surgery. The information in this particular review is derived from textbooks, current literature, and personal experience, and is designed as a general overview of anesthesia during cardiac surgery.
-
J Extra Corpor Technol · Jun 2005
Case ReportsCardiopulmonary bypass in pregnancy: possible new role for the intra-aortic balloon pump.
Cardiopulmonary bypass (CPB) during pregnancy is associated with a maternal mortality similar to the nonpregnant population; however, fetal morbidity and mortality are high. Various strategies to improve fetal survival have been advocated. ⋯ In the first, the IABP was inserted after termination of a long bypass, specifically in an attempt to improve uterine perfusion and thereby relieve a profound fetal bradycardia. In the second, the IABP was used electively to provide pulsatile flow during the bypass period primarily to benefit fetal hemodynamics.
-
J Extra Corpor Technol · Jun 2005
Cardiopulmonary bypass in conscious patients undergoing cardiac surgery.
This study was undertaken to evaluate the feasibility of thoracic epidural anesthesia as an alternative technique to general anesthesia in patients undergoing cardiac surgery under cardiopulmonary bypass. This prospective study was conducted in a tertiary referral hospital. Seventeen patients underwent cardiac surgical procedures requiring cardiopulmonary bypass without general anesthesia under thoracic epidural anesthesia from February to May 2004. ⋯ None of the patients required conversion to general anesthesia. There was no mortality or morbidity in this series and to our knowledge our series is the first such. Cardiac surgical procedures requiring cardiopulmonary bypass may be conducted under thoracic epidural anesthesia, without endotracheal general anesthesia.
-
J Extra Corpor Technol · Jun 2005
In vitro validation of the Affinity NT oxygenator arterial outlet temperatures.
During cardiopulmonary bypass, the rates of cooling and rewarming and the maximum temperatures attained are implicated in patient morbidity. Thus, accurate oxygenator arterial outlet temperature measurements are needed. The purpose of this study was to determine the accuracy of the arterial outlet temperature probe on the "Affinity NT" membrane oxygenator in measuring perfusate temperatures. ⋯ An overestimation of the perfusate temperatures occurred during early cooling (bias of -0.57 degrees C; precision of +/-1.37 degrees C). Only during the late cooling phase was the arterial outlet temperature probe accurate (bias of -0.02 degrees C; precision of +/-0.3 degrees C). The perfusionist should be aware of the temperature probe monitoring characteristics of the oxygenator to safely perfuse the patient.